Bank Of Nova Scotia Nuvasive Inc Transaction History

Bank Of Nova Scotia

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$36.71 - $44.15 $511,553 - $615,230	-13,935 Reduced 30.17%	32,248 $1.34 Million
Q1 2023 May 11, 2023	SELL	$36.81 - $48.12 $717,795 - $938,340	-19,500 Reduced 29.69%	46,183 $1.91 Million
Q4 2022 Feb 09, 2023	SELL	$35.68 - $44.71 $2.86 Million - $3.58 Million	-80,050 Reduced 54.93%	65,683 $2.71 Million
Q2 2022 Aug 08, 2022	BUY	$46.84 - $59.75 $6.83 Million - $8.71 Million	145,733 New	145,733 $7.16 Million
Q2 2022 Aug 05, 2022	SELL	$46.84 - $59.75 $6.83 Million - $8.71 Million	-145,733 Closed	0 $0

Q4 2021 Feb 11, 2022	SELL	$47.19 - $62.68 $2.08 Million - $2.76 Million	-44,000 Reduced 23.19%	145,733 $7.65 Million
Q2 2021 Aug 12, 2021	BUY	$64.02 - $71.72 $12.1 Million - $13.6 Million	189,733 New	189,733 $12.9 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.